Top News

New First Line Treatment Now Available for Canadians with Metastatic Non-Small Cell Lung Cancer

September 22, 2017

KIRKLAND, QC, Sept. 20, 2017 /CNW Telbec/ – Merck (NYSE: MRK), known as MSD outside Canada and the United States, announced today that KEYTRUDA® (pembrolizumab) as monotherapy is now indicated for the treatment of metastatic non-small cell lung cancer (NSCLC) in adults whose tumours have high PD-L1 expression, with no EGFR or ALK genomic tumour aberrations and no prior systemic chemotherapy treatment. A

Read More

First-in-class BRCA-positive Ovarian Cancer Medicine Lynparza® (olaparib) Receives Positive pan-Canadian Oncology Drug Review (pCODR) Recommendation for Provincial Reimbursement

September 21, 2017

This marks an important first step towards providing Canadian women with access to this treatment MISSISSAUGA, ON, Sept. 21, 2017 /CNW/ – AstraZeneca Canada is pleased to announce that the pan-Canadian Oncology Drug Review (pCODR) has provided an overwhelmingly positive clinical recommendation for the reimbursement of Lynparza® (olaparib), a first-of-its-kind treatment for BRCA-mutated ovarian cancer.1 Lynparza is an oral, potent

Read More

Cancer-Associated Thrombosis: A Critical Gap in Cancer Care

September 14, 2017

“Cancer-associated thrombosis (CAT) is one of the most common yet preventable causes of death among cancer patients. With over 20,000 Canadians being diagnosed with cancer each year, knowing about causes, prevention, and treatment of CAT will be critical to the quality of life and long-term survival of these individuals. CAT refers to blood clots that can

Read More

Upcoming Events

  • Sep25
    2017 CACHC Conference & AGM

    This September, join delegates from across Canada as we explore multi-sector innovations in community-based health and social services and address key social factors impacting health. Conference Highlights Hear from members of the Calgary Recovery Services Task Force, a formal health, housing and social services collaboration among 26 homeless serving agencies, government, and other community stakeholders,

    View Event
  • Sep26
    Sickle Cell Awareness Event

    September is sickle cell awareness month and the Sickle Cell Awareness Groups of Ontario (SCAGO) invites you to the following event: Sickle Cell Awareness Event Date: September 26th 2017 Time: 11am- 2pm Location: Atrium/Patio; Hospital For Sick Children. Toronto, ON Contact: secretary@sicklecellanemia.ca

    View Event
  • Sep27
    Kidney Cancer Canada National Online Meeting

    Vancouver Cancer Centre Oncologist, Dr. Christian Kollmannsberger and Juravinski Cancer Centre Uro-Oncologist, Dr. Anil Kapoor lead this free information that brings you the latest news from the European Society Medical Oncology Annual Congress. Dr. Kapoor and Dr. Kollmannsberger are joined by patient Hélène Veilleux for this special session that provides you with the chance to

    View Event
View All Events

Participate

  • The MATCH Study: Now Recruiting!

    CKN is pleased to have partnered with Dr. Linda Carlson and her research team at the University of Calgary and the Princess Margaret Cancer Centre, in a ground-breaking new study measuring the effects of Mindfulness Meditation and Tai Chi/Qigong on quality of life for cancer survivors.Participate Now

  • Thinking About Biosimilars – Patient Survey

    This survey is a patient-led initiative conducted by the Canadian Organization for Rare Disorders.Participate Now

  • Consultation: mandatory reporting of serious adverse drug reactions and medical device incidents

    You’re invited to comment on proposed changes to the Food and Drug Regulations and Medical Devices Regulations. These changes would make it mandatory for health care institutions to report serious adverse drug reactions (ADRs) and medical device incidents (MDIs).Participate Now

  • Seeking Participants for Survey on Breast Cancer & Work

    The Work Wellness Lab at Saint Mary’s University (Halifax, NS) is conducting a survey study on the work experiences of women who have been diagnosed with breast cancer. The study is aimed at all Canadian women 18 years of age and over diagnosed with breast cancer within the past 2 years and who were working at the time of diagnosis.Participate Now

View All Items

Survivor Stories

Surviving and Thriving – Suzanne Doré

The journey to my diagnosis with advanced stage bowel cancer was an unusual one. Six months prior to my diagnosis, our world had fallen apart. Our son Sam, who was 13 at the time, was diagnosed with advanced stage nasopharyngeal carcinoma. This type of cancer is very rare in the west for adults, let alone

Read More

Leukemia Didn’t Beat Me. I Beat It! – Jason Clark

Being diagnosed with acute leukemia was the most devastating and life-changing event I have ever faced. I was 35, healthy, and fit. I never drank or smoked. About a month before my diagnosis, I got really sick. I thought I had the flu. I was being stubborn and wouldn’t go to the doctor to get

Read More
All Stories

Join the Conversation

On Twitter

« Il s’agit d’une avancée importante pour les Canadiennes aux prises avec un cancer de l’ovaire »… twitter.com/i/web/status/9…

Retweets
0
Favorites
0

Our Webinar Series is back! Register now for Thursday's free webinar regarding the proposed changes to PMPRB!… twitter.com/i/web/status/9…

Retweets
0
Favorites
0

"This is a great step forward for Canadian women living with BRCA-mutated ovarian cancer" bit.ly/2wLGf3w

Retweets
1
Favorites
1
Follow Us On Twitter

On Facebook

Don’t miss the Canadian Cancer Survivor Network’s next webinar on How Changes to the Patented Medicine Prices Review Board Could Affect Patients' Access to Drugs! This webinar will introduce you to the Patented Medicine Prices Review Board (PMPRB), how they regulate drug pricing in Canada and the proposed changes that will affect cancer patients. This webinar will also provide you with the following information: • Summary, analysis and next steps regarding proposed price regulation changes • Patient perspectives on the proposed reforms • Discussion on potential impact, issues and opportunities from these proposed changes • How patients and patient groups can engage on the issue to ensure their voices are heard https://register.gotowebinar.com/register/8478486279925031683

Comments
3
Like Us On Faceook

Donate

Donate Now

Your donation helps us to fund research and encourage research on ways to alleviate barriers to optimal patient care and follow-up.

Donate Now